ResearcherHospital Universitario de CrucesActive in the last 2 years

Alberto Muñoz Llarena

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 trial

Trials 1

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) Principal investigator NCT07284277 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fernando Garicano Goldaraz · 1 shared trial, 2025 · strength 0.49
- Trial TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) NCT07284277 ↗
Ángela Lamarca Lete · 1 shared trial, 2025 · strength 0.49
- Trial TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) NCT07284277 ↗
Patricia Seoane Couselo · 1 shared trial, 2025 · strength 0.49
- Trial TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) NCT07284277 ↗
Mariano Ponz Sarvisé · 1 shared trial, 2025 · strength 0.49
- Trial TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC) NCT07284277 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.